slides · global inventory
Plan Implementation
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,044
Current window 3,901-3,930
Pages 202
Rows per page 30
Slide function
3,901-3,930 of 6,044
14
The slide outlines a clinical trial protocol with specific patient counts (n=12, n=8) and timeline milestones (weeks 1, 24, 28, 40, 52).Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
16
Shows two parallel study arms with randomization at week 24/26.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
23
The slide outlines a multi-part clinical trial structure with specific cohort sizes and dosing progression.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
25
The slide includes a financial disclaimer regarding cash balance and burn.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a circular/concentric layout to represent the 'horizon' of opportunities, with the pipeline on the left and commercial/development milestones on the right.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Early StrugglesLoop · Why Now1 hit
13
The slide highlights the progression of delivery technology enabled by the ENHANZE license.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Why Now1 hit
14
Uses a pyramid-like growth visualization to represent expanding market opportunities.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Why Now1 hit
24
argenx SE | Investor Conference Presentation Deck | 27 slidesargenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
19
The slide highlights both internal R&D focus areas and external acquisitions (Cellectis, Quell, Gracell) to support long-term growth.AstraZeneca | Investor Conference Presentation Deck | 26 slides · AstraZeneca
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
04
The slide uses a Gantt-style visualization to show drug development progress across Preclinical, Phase 1, Phase 2, and Phase 3 stages.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a table-like structure to track progress (checkmarks for completed, squares for upcoming) across 8 distinct drug programs.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide outlines a 12-week open-label study with a specific focus on treatment-resistant depression (TRD).ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide uses a timeline-based process diagram to illustrate the clinical trial flow.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide outlines two distinct study designs (COMP 005 and COMP 006) with specific primary endpoints at week 6.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
Includes trial objectives and timeline markers for both parts.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
29
The slide uses a standard clinical trial flow diagram showing randomization into three arms (40mg, 20mg, placebo) over a 6-week period.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
08
The chart uses a Gantt-style visualization to show the progress of drug candidates through clinical phases.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
12
The diagram illustrates a dose escalation study design with combination therapy.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
22
The slide uses a process flow diagram to map patient segments to specific dosing regimens and clinical goals.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations 1 hit
28
Details specific patient enrollment numbers (~80 total, ~60 for primary analysis) and dosing randomization criteria.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations Beat · Market Sizing1 hit
41
BioAtla | Investor Presentation Deck | 55 slidesBioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations 1 hit
53
The slide details the dose escalation strategy using accelerated, standard, and priming titration cohorts.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations 1 hit
54
The slide uses a simple 2-column table structure to represent a timeline.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations Beat · Why Now1 hit
25
Crocs | Investor Presentation Deck | 29 slidesCrocs | Investor Presentation Deck | 29 slides · Crocs
Pitch deck Investor relations 1 hit
14
D-Wave | Investor Conference Presentation Deck | 20 slidesD-Wave | Investor Conference Presentation Deck | 20 slides · D-Wave
Conference presentation Investor relations Beat · Rising Success1 hit
12
Uses a chevron-style visual to imply forward momentum from past achievements to future goals.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations Beat · Solution & ApproachLoop · Aha Moment1 hit
37
The slide combines a project timeline with a summary of quantitative and qualitative benefits.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
41
The slide uses a timeline framework to correlate project milestones with quantitative labor savings.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
101
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
114
The slide uses a timeline diagram to show progress milestones.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit